Women's and Children's Hospital
Gaziantep, 27270, Turkey (Türkiye)
NCT Number: NCT07580885
Effect of Virtual Reality-Assisted Nursing Intervention on Pain and Anxiety During Intrauterine Device Insertion: A Randomized Controlled Trial April 30, 2026 The aim of this study was to evaluate the effect of a virtual reality-assisted nursing intervention on participants' pain, anxiety, physiological parameters and comfort levels during Intrauterine Device (IUD) insertion. In this context, the study which hypothesises that the virtual reality application will reduce pain and anxiety during the procedure, support physiological stability, and enhance participants' comfort levels was designed as a randomised controlled trial.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Gaziantep, 27270, Turkey (Türkiye)
The study's hypotheses:
Individuals receiving the virtual reality-supported nursing intervention (experimental group), compared to the control group (not individuals receiving the virtual reality);
Within the scope of the study, a total of 89 women were approached, and 12 declined to participate. Considering potential data loss, 77 participants were enrolled in the study. Following the pre-test, 7 participants who did not meet the inclusion criteria were excluded. No participants withdrew during the intrauterine device insertion procedure, and the study was completed with 70 participants (experimental = 35, control = 35).
Figure 1. CONSORT flow diagram
Randomisation and Groups In this study, given the nature of the intervention, it was anticipated that conducting the experimental and control groups on the same day could lead to information transfer between participants via communication (contamination) and behaviour changes related to the intervention (Hawthorne effect). Furthermore, administering the virtual reality application to some participants whilst not administering it to others within the same clinical setting could create a perception of unequal treatment among individuals, which could influence the study results.
Therefore, to minimise the risk of contamination and maintain the integrity of the clinical trial, participants were assigned to groups on a day-by-day basis. Participants who enrolled on specific days of the week were included in the experimental group, whilst those who enrolled on other days were included in the control group.
The similarity of baseline characteristics between the groups will be assessed statistically.
Intervention
Experimental Group (individuals receiving the virtual reality):
Participants in the experimental group were subjected to a virtual reality-assisted nursing intervention during the IUD insertion procedure. As part of this, participants were shown a 3D video lasting approximately 6 minutes, featuring nature-themed scenes (water, forest, sky) and accompanied by soothing music, via virtual reality goggles.
This intervention was designed as a non-pharmacological nursing intervention aimed at diverting the individual's attention away from the procedure and reducing pain and anxiety levels.
Control Group (not individuals receiving the virtual reality):
Participants in the control group will not receive any additional interventions beyond the routine care provided in the clinic during the IUD insertion procedure.
Data Collection Tools Data were collected in three phases: pre-procedure, during the procedure, and post-procedure.
Pre-procedure: A 7-item Information Form comprising demographic and descriptive characteristics; a 48-items the General Comfort Scale (GCS) and a 4-item Visual Analogue Scale (VAS) assessing anxiety, fear/apprehension, irritability and satisfaction regarding the IUD procedure, and by assessing blood pressure, pulse and respiratory rate.
During the procedure, pain levels immediately following the insertion of the speculum, tenaculum and IUD will be assessed using the VAS, and the pulse will be checked at each stage.
Five minutes after the procedure, blood pressure, pulse, and respiratory rate were assessed, and a 5-item VAS covering pain, tension, fear/anxiety, irritability, and satisfaction regarding the IUD insertion will be administered, along with the General Comfort Scale.
The study data were collected between February 2024 and December 2025. Ethical approval was obtained from the SANKO University Clinical Research Ethics Committee with decision number 2023-24. Informed consent was obtained from the participants.
General Comfort Scale: Developed by Kolcaba in 1992, and with Turkish validity and reliability studies conducted by Kuğuoğlu & Karabacak in 2008, this is a four-point Likert-type scale consisting of three sub-dimensions (comfort, relaxation, superiority) and 48 items. The scale includes both positive and negative items, with negative items being reverse-coded. The total score obtained from the scale is divided by the number of items to find the average score. The minimum score on the scale is 48, and the maximum is 192. Based on the average scores obtained from the comfort scale, a score of 0-48 indicates a poor level, 49-96 indicates a moderate level, 50-144 indicates a good level, and 145-192 indicates a very good level. A higher score indicates a high level of comfort. The Cronbach's alpha value of the Turkish form of the scale is .85. In this study, both groups were evaluated together and the score was found to be 0.815 based on pre-test results.
Visual Analog Scale (VAS): Created by Albersnagel (1998), the VAS is a measurement tool in which each of 18 emotion expressions is placed on a separate plane. The scale consists of emotion adjectives where the person marks each emotion they are currently experiencing with a vertical line on a plane. Each emotion is rated between not experiencing the emotion at all (e.g., not at all tense = 0) and being fully experienced (e.g., extremely tense = 100). The VAS evaluates four emotion categories: Dysphoria, Hostility, Anxiety, and Positive Affect. Dysphoria includes adjectives such as depressed, sad, mournful, distressed, hopeless, and miserable. Hostility includes adjectives such as angry, rebellious, restless, and hostile. Anxiety includes adjectives such as anxious, uneasy, tense, and nervous. Positive Emotion consists of the adjectives happy, content, cheerful, and satisfied. Scoring is based on measuring the vertical markings made by the participant for each emotion on a plane using a ruler. Positive emotion adjectives are items that are reversed during scoring. In the Turkish validity and reliability study by Aydın et al. (2011), the scale was grouped under three factors: anxiety/unease, hostility, and positive emotion. The distribution of emotions according to these factors consists of the adjectives: Anxiety/Unease (depressed, sad, sorrowful, in distress, hopeless, miserable, worried, anxious, uneasy, tense, restless), hostility (angry, rebellious, irritable), and positive emotion (happy, content, cheerful, satisfied). According to the Turkish validity and reliability study, the Cronbach Alpha coefficients of the scale were found to be .93 for the Anxiety/Unease factor, .84 for the Positive Emotion factor, and .73 for the Hostility factor.
Materials to be Used in the Study:
Data Collection Data will be collected by trained researchers using the face-to-face interview method. The data collection process will take an average of 15-20 minutes.
Participants will be informed about the research and an "Informed Consent Form" will be administered. The researcher will know who is in the experimental and control groups, but participants will not know which group they belong to. Participants will be blinded. Due to the nature of the research, the researcher cannot be blinded. When the research is complete, the data will be transferred to a computer environment by an independent researcher who does not know groups A and B, and the data will be analyzed by a statistician and the findings reported.
Statistical Analysis Data analysis will be conducted using the SPSS programme.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention Name: Virtual Reality Intervention
Description:
Participants in the experimental group received a virtual reality-assisted nursing intervention during intrauterine device insertion. A virtual reality headset was used to present a 3D immersive video including relaxing natural scenes and calming background music. The intervention was applied continuously throughout the procedure to distract attention from the procedure and reduce pain and anxiety.
Intervention Name: Routine Care
Description:
Participants in the control group received routine care during intrauterine device insertion without the use of virtual reality or any additional distraction method.
Time frame: Immediately post-procedure (speculum, tenaculum, immediately after insertion, and post-procedure)
Pain intensity experienced during intrauterine device insertion, measured using a Visual Analog Scale.The score obtained from the scale ranges from 0 to 10. 0 means no pain, and 10 describes the most severe form of pain.
Time frame: Immediately post-procedure (speculum, tenaculum, immediately after insertion, and post-procedure)
Anxiety levels assessed using a Visual Analog Scale during the procedure.The score obtained from the scale ranges from 0 to 10. 0 indicates no anxiety, while 10 describes the most severe level of anxiety.
Time frame: 5 minutes before starting the IUD insertion procedure and 5 minutes after completing the IUD insertion procedure.
Patient comfort assessed using the General Comfort Scale before and after the procedure
Mersin University
Other
Effect of Virtual Reality-Assisted Nursing Intervention on Pain and Anxiety During Intrauterine Device Insertion: A Randomized Controlled Trial
Acronym: VR-IUD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03680625
Acute Pain, Agnosia
Montreal, Quebec, Canada
View Trial DetailsNCT07334522
Agnosia, Anxiety
Karbala, Iraq
View Trial DetailsNCT07652957
Agnosia, Anxiety
Antalya, Center, Turkey (Türkiye)
View Trial DetailsNCT07483619
Agnosia, Anxiety
Istanbul, Turkey (Türkiye)
View Trial Details